Nucleic acid-binding photoprobes and uses thereof

By using small molecule ligands with tethering groups to bind to RNA, identify and regulate RNA binding sites, we solve the delivery and permeability challenges in RNA-mediated disease treatment and achieve precise regulation of RNA transcripts. Provides new treatment avenues.

CN111386127AInactive Publication Date: 2020-07-07ARRAKIS THERAPEUTICS INC
16 Cites 0 Cited by

Patent Information

Application Number
CN201880076222.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2017-11-30
Filing Date
2018-11-30
Publication Date
2020-07-07
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing technologies are difficult to effectively identify and regulate the RNA transcriptome, especially in drug delivery, absorption, distribution and cell penetration. The lack of validated small molecule screening methods for RNA targets limits the treatment of RNA-mediated diseases. Effect.

Method used

By using small molecule ligands with attachment points for tethering groups to bind to RNA, combined assays identify the binding and active sites of the RNA and modulate the structure and function of the RNA, thereby developing treatments that modulate RNA transcripts. method.

Benefits of technology

It achieves precise regulation of RNA transcripts, improves drug delivery efficiency and cell permeability, and provides new ways to treat RNA-mediated diseases, especially in the regulation of mRNA, non-coding RNA and repetitive sequence RNA. potential.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to photo-activated compounds and methods of use thereof for determining binding site and other structural information about RNA transcripts. The invention also provides methods of identifying RNA transcripts that bind compounds and are thus druggable, methods of screening drug candidates, and methods of determining drug binding sites and / or accessible or reactive sites on a target RNA.
Need to check novelty before this filing date? Find Prior Art